Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Stephen Liu
Johns Hopkins University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
AstraZeneca, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Dr. Stephen Liu is a co-investigator on this research. He serves as a paid consultant for AstraZeneca, which is the maker of the investigational drug being tested in this study. The outcome of the research could affect the financial interest of AstraZeneca.
The Johns Hopkins Translational Science Team for the ET-CTN
RELEVANCE: Our Team will continue its long-standing contribution to the drug development efforts of the NCI through UM1-based project teams. We anticipate that our contribution within the Network will impact the clinical care of cancer patients. We anticipate enhanced interactions with the National Clinical Trials Network (NCTN) through our ECOG-ACRIN affiliation to bring forward successes from the efforts of the ET-CTN.
Filed on June 07, 2018.
Tell us what you know about Stephen Liu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Stephen Liu”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Stephen Liu | Johns Hopkins University | Conflict of Interest | AstraZeneca, Inc. | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.